EV/EBITDA
-3.70
+0.03+0.80%
Fri, 07 Feb 2025 22:48:20 GMT
Summary
- As of February 8, 2025, KPTI EV/EBITDA is -3.70, with a rise of +0.03 (+0.80%) during the most recent trading day.
- Over the past year, KPTI EV/EBITDA has dropped by -1.19 (-47.41%).
- KPTI EV/EBITDA is now -230.36% below its all-time high of -1.12.
Performance
KPTI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KPTI EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +0.8% | -0.9% | -2.2% |
1 m1 month | +9.8% | -9.8% | -21.5% |
3 m3 months | +14.8% | -14.8% | -30.5% |
6 m6 months | -7.6% | -6.0% | -23.1% |
ytdytd | +2.6% | -2.7% | -6.5% |
1 y1 year | -47.4% | -32.3% | -57.6% |
5 y5 years | +39.8% | -82.1% | -96.3% |
KPTI EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -1.4% | -4.10 | +9.8% | |
3 m | 3-month | -3.65 | -1.4% | -4.35 | +14.9% |
6 m | 6-month | -3.17 | -16.7% | -4.58 | +19.2% |
1 y | 1-year | -2.14 | -72.9% | -4.58 | +19.2% |
3 y | 3-year | -1.74 | -112.6% | -11.13 | +66.8% |
5 y | 5-year | -1.74 | -112.6% | -11.13 | +66.8% |
alltime | all time | -1.12 | -230.4% | -33.48 | +89.0% |
Karyopharm Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -3.70(-2.6%) |
2024 | -3.80(+102.1%) |
2023 | -1.88(-39.2%) |
2022 | -3.09(-37.2%) |
2021 | -4.92(-30.6%) |
2020 | -7.09(+3.8%) |
Date | Value |
---|---|
2019 | -6.83(+115.5%) |
2018 | -3.17(0.0%) |
2017 | -3.17(+0.3%) |
2016 | -3.16(-10.2%) |
2015 | -3.52(-75.2%) |
2014 | -14.22(-8.0%) |
2013 | -15.45 |
FAQ
- What is Karyopharm Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Karyopharm Therapeutics?
- What is KPTI EV/EBITDA year-to-date change?
- What is Karyopharm Therapeutics EV/EBITDA year-on-year change?
What is Karyopharm Therapeutics EV/EBITDA?
The current EV/EBITDA of KPTI is -3.70
What is the all time high EV/EBITDA for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high EV/EBITDA is -1.12
What is KPTI EV/EBITDA year-to-date change?
Karyopharm Therapeutics EV/EBITDA has changed by +0.10 (+2.63%) since the beginning of the year
What is Karyopharm Therapeutics EV/EBITDA year-on-year change?
Over the past year, KPTI EV/EBITDA has changed by -1.19 (-47.41%)